These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31693255)

  • 21. Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway.
    Lombardi APG; Vicente CM; Porto CS
    Front Endocrinol (Lausanne); 2020; 11():184. PubMed ID: 32328032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
    Omoto Y; Iwase H
    Cancer Sci; 2015 Apr; 106(4):337-43. PubMed ID: 25611678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
    Ellem SJ; Risbridger GP
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
    Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.
    Feng J; Li L; Zhang N; Liu J; Zhang L; Gao H; Wang G; Li Y; Zhang Y; Li X; Liu D; Lu J; Huang B
    Oncogene; 2017 May; 36(20):2775-2790. PubMed ID: 27893717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer.
    Bimonte VM; Catanzaro G; Po A; Trocchianesi S; Besharat ZM; Spinello Z; Curreli M; Fabi A; Bei R; Milella M; Vacca A; Ferretti E; Migliaccio S
    Endocrine; 2024 Mar; 83(3):798-809. PubMed ID: 37979099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
    Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
    Zellweger T; Stürm S; Rey S; Zlobec I; Gsponer JR; Rentsch CA; Terracciano LM; Bachmann A; Bubendorf L; Ruiz C
    Endocr Relat Cancer; 2013 Jun; 20(3):403-13. PubMed ID: 23580588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane-initiated estrogen signaling in prostate cancer: A route to epithelial-to-mesenchymal transition.
    Gadkar S; Nair S; Patil S; Kalamani S; Bandivdekar A; Patel V; Chaudhari U; Sachdeva G
    Mol Carcinog; 2019 Nov; 58(11):2077-2090. PubMed ID: 31411358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.
    Bayala B; Zoure AA; Baron S; de Joussineau C; Simpore J; Lobaccaro JA
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456259
    [No Abstract]   [Full Text] [Related]  

  • 35. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
    Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.
    Lundqvist J; Norlin M; Wikvall K
    Biochim Biophys Acta; 2011 Apr; 1811(4):263-70. PubMed ID: 21262387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
    Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing roles of steroid nuclear receptors with prostate cancer progression.
    Savoy RM; Ghosh PM
    Endocr Relat Cancer; 2013 Aug; 20(4):C9-11. PubMed ID: 23744763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.